Pathophysiology of idiopathic pulmonary fibrosis

被引:2
|
作者
Crestani, Bruno [1 ,2 ,3 ]
机构
[1] Hop Bichat Claude Bernard, F-75018 Paris, France
[2] INSERM, U700, Fac Xavier Bichat, F-75018 Paris, France
[3] Univ Paris 07, Paris, France
来源
关键词
IDIOPATHIC PULMONARY FIBROSIS; FIBROBLASTS; CELL TRANSDIFFERENTIATION; EPITHELIAL-MESENCHYMAL TRANSITION; INTERSTITIAL PNEUMONIA; CELL DEATH; FIBROCYTES; FIBROBLASTS; INDUCTION; ACTIVATION; APOPTOSIS;
D O I
10.1016/S0001-4079(19)32326-X
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Despite renewed interest in IPF, the precise biological mechanisms underlying the development of pulmonary fibrosis and irreversible lung destruction remain elusive. Inflammation seems to play a minor role at initial onset. Excessive apoptosis of alveolar epithelial cells in this setting suggests that IPF may result from repeated alveolar epithelial cell injury and activation. This would induce the recruitment, proliferation and activation of mesenchymal cells, leading to the formation of fibroblastic foci and abnormal accumulation of extracellular matrix. The fibroblastic foci are inter-connected in a three-dimensional reticulum. Circulating mesenchymal precursors called fibrocytes, and transdifferentiation of epithelial cells, endothelial cells and/or mesothelial cells, may all contribute to fibroblast accumulation in the lung.
引用
收藏
页码:343 / 351
页数:9
相关论文
共 50 条
  • [1] Pathophysiology of idiopathic pulmonary fibrosis DISCUSSION
    Larcan, Alain
    Ardaillou, Raymond
    Michel, Francois-Bernard
    Rondot, Pierre
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2010, 194 (02): : 351 - 352
  • [2] Unravelling the progressive pathophysiology of idiopathic pulmonary fibrosis
    Guenther, Andreas
    Korfei, Martina
    Mahavadi, Poornima
    von der Beck, Daniel
    Ruppert, Clemens
    Markart, Philipp
    EUROPEAN RESPIRATORY REVIEW, 2012, 21 (124): : 152 - 160
  • [3] ROLE OF MATRIX METALLOPROTEINASES IN THE PATHOPHYSIOLOGY OF IDIOPATHIC PULMONARY FIBROSIS
    Bhattacharyya, P.
    Acharya, D.
    Roychowdhury, S.
    LUNG INDIA, 2007, 24 (02) : 61 - 65
  • [4] A novel pulmonary fibroblast model to study the pathophysiology of idiopathic pulmonary fibrosis
    Schundner, A.
    Nemeth, J. K.
    Dietl, P.
    Frick, M.
    ACTA PHYSIOLOGICA, 2019, 227
  • [5] Pathophysiology of small airways in idiopathic pulmonary fibrosis (IPF): the silent zone
    Lu, Wenying
    Shahzad, Affan Mahmood
    Simon, Athul Antony
    Haug, Greg
    Waters, Maddison
    Sohal, Sukhwinder Singh
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2025, 19 (03) : 195 - 203
  • [6] Genetic Association Study Advances Idiopathic Pulmonary Fibrosis Pathophysiology and Health Equity
    Hobbs, Brian D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 206 (01) : 4 - 5
  • [7] Idiopathic pulmonary fibrosis (IPF): disease pathophysiology, targets, and potential therapeutic interventions
    Saha, Pritha
    Talwar, Priti
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2024, 479 (09) : 2181 - 2194
  • [8] Using Quantitative Systems Pharmacology Modeling to Understand the Pathophysiology of Idiopathic Pulmonary Fibrosis
    Siler, S. Q.
    Longo, D.
    Woodhead, J.
    Battista, C.
    Kenz, Z.
    Tallapaka, S.
    Liu, G.
    Generaux, G.
    Ermakov, S.
    Shoda, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [9] Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis
    Strykowski, Rachel
    Adegunsoye, Ayodeji
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2023, 43 (02) : 209 - 228
  • [10] Autotaxin in Pathophysiology and Pulmonary Fibrosis
    Ninou, Joanna
    Magkrioti, Christiana
    Aidinis, Vassilis
    FRONTIERS IN MEDICINE, 2018, 5